William T. Comer
Amministratore Delegato presso NeuroGenetic Pharmaceuticals, Inc.
Profilo
William T.
Comer is the founder and currently holds the position of Chairman & Chief Executive Officer at NeuroGenetic Pharmaceuticals, Inc. which was founded in 2009.
He is also currently serving as an Independent Director at Tetragenex Pharmaceuticals, Inc. since 2001, as a Director at La Jolla Institute for Molecular Medicine since 2000, and as a Trustee-Emeritus at UC San Diego Foundation.
In the past, Dr. Comer held the position of President & Chief Executive Officer at Sibia Neurosciences, Inc. from 1991 to 1999.
He also served as Chairman & Chief Executive Officer at TorreyPines Therapeutics, Inc., Chairman at PNO Resources Ltd., Director at Trega Biosciences, Inc., Director at Epimmune, Inc., Director at TRACON Pharmaceuticals, Inc., and Director at IDM Pharma, Inc. Additionally, he was a Director at TorreyPines Therapeutics, Inc. from 2006 to 2007 and Senior Vice President-Strategic Management at Bristol Myers Squibb Co. from 1982 to 1991.
Dr. Comer completed his undergraduate degree at Carleton College in 1957 and obtained his doctorate degree from the University of Iowa in 1961.
Posizioni attive di William T. Comer
| Società | Posizione | Inizio |
|---|---|---|
Tetragenex Pharmaceuticals, Inc.
 Tetragenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetragenex Pharmaceuticals, Inc. operates as a biotechnology company. It develops and commercializes proprietary pharmaceutical products for use in treatment resistant depression and other central nervous system diseases in the United States. The firm's principal product is Nemifitide, an antidepressant compound, which is in Phase II clinical trials for the treatment of depression, anxiety, and other central nervous system disorders. The company was founded in 1989 and is headquartered in Syosset, NY. | Direttore/Membro del Consiglio | 05/02/2010 |
| La Jolla Institute for Molecular Medicine | Direttore/Membro del Consiglio | 05/02/2010 |
NeuroGenetic Pharmaceuticals, Inc.
 NeuroGenetic Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NeuroGenetic Pharmaceuticals, Inc. discovers and develops drugs for the prevention of neurodegenerative conditions. The company was founded by William T. Comer, Rudy Tanzi and Steven L. Wagner in 2009 and is headquartered in Del Mar, CA. | Amministratore Delegato | 01/01/2009 |
UC San Diego Foundation
 UC San Diego Foundation Investment Trusts/Mutual FundsMiscellaneous UC San Diego Foundation specializes in obtaining private gifts in support of research, teaching, and public service, as well as engages in management of gift assets. The company is was founded in 1972 and is headquartered in La Jolla, CA. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di William T. Comer
| Società | Posizione | Fine |
|---|---|---|
TorreyPines Therapeutics, Inc.
 TorreyPines Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology TorreyPines Therapeutics, Inc. manufactures and distributes biopharmaceutical products. The company develops small molecule drugs to treat diseases and disorders of the central nervous system, chronic pain, neuropathic pain, cognitive disorders and alzheimer's disease. It was formerly known as Axonyx, Inc. The company is headquartered in La Jolla, CA. | Direttore/Membro del Consiglio | 23/05/2007 |
| Epimmune, Inc. | Direttore/Membro del Consiglio | 17/08/2005 |
| Sibia Neurosciences, Inc. | Presidente | 02/01/1999 |
Trega Biosciences, Inc.
 Trega Biosciences, Inc. BiotechnologyHealth Technology Trega Biosciences, Inc. was a drug discovery company, utilizing combinatorial chemistry and other technologies to pursue the discovery of novel, small-molecule drug therapies. The company leveraged its technology platform by entering into pharmaceutical alliances, enabling partners to access its technologies in exchange for licensing fees and potential milestone payments and royalties or by establishing joint-discovery alliances with biotechnology companies. The company used its drug discovery technologies in its internal development programs. It was headquartered in San Diego, CA. The compnay was acquired by LION bioscience AG | Direttore/Membro del Consiglio | 02/01/1996 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 02/01/1991 |
Formazione di William T. Comer
| Carleton College | Undergraduate Degree |
| University of Iowa | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| TRACON PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 11 |
|---|---|
| Sibia Neurosciences, Inc. | Health Technology |
Trega Biosciences, Inc.
Trega Biosciences, Inc. BiotechnologyHealth Technology Trega Biosciences, Inc. was a drug discovery company, utilizing combinatorial chemistry and other technologies to pursue the discovery of novel, small-molecule drug therapies. The company leveraged its technology platform by entering into pharmaceutical alliances, enabling partners to access its technologies in exchange for licensing fees and potential milestone payments and royalties or by establishing joint-discovery alliances with biotechnology companies. The company used its drug discovery technologies in its internal development programs. It was headquartered in San Diego, CA. The compnay was acquired by LION bioscience AG | Health Technology |
| Epimmune, Inc. | Health Technology |
PNO Resources Ltd.
 PNO Resources Ltd. Other Metals/MineralsNon-Energy Minerals PNO Resources Ltd. engages in the acquisition and exploration of natural resource properties. The company was founded on February 22, 1983 and is headquartered in Vancouver, Canada. | Non-Energy Minerals |
Tetragenex Pharmaceuticals, Inc.
Tetragenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetragenex Pharmaceuticals, Inc. operates as a biotechnology company. It develops and commercializes proprietary pharmaceutical products for use in treatment resistant depression and other central nervous system diseases in the United States. The firm's principal product is Nemifitide, an antidepressant compound, which is in Phase II clinical trials for the treatment of depression, anxiety, and other central nervous system disorders. The company was founded in 1989 and is headquartered in Syosset, NY. | Health Technology |
NeuroGenetic Pharmaceuticals, Inc.
NeuroGenetic Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NeuroGenetic Pharmaceuticals, Inc. discovers and develops drugs for the prevention of neurodegenerative conditions. The company was founded by William T. Comer, Rudy Tanzi and Steven L. Wagner in 2009 and is headquartered in Del Mar, CA. | Health Technology |
TorreyPines Therapeutics, Inc. /Old/
 TorreyPines Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology TorreyPines Therapeutics, formerly Neurogenetics, Inc., was founded in 2000. The company discovers & develops small molecule drugs to treat diseases and disorders of the central nervous system. The company is located in La Jolla, CA | Health Technology |
IDM Pharma, Inc.
 IDM Pharma, Inc. Pharmaceuticals: MajorHealth Technology IDM Pharma, Inc. develops products for the destruction of cancer cells. Its products activate the immune system or prevent recurrence by triggering adaptive immune response. The company was founded in established on October 1987 and is headquartered in Cambridge, MA. | Health Technology |
TorreyPines Therapeutics, Inc.
TorreyPines Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology TorreyPines Therapeutics, Inc. manufactures and distributes biopharmaceutical products. The company develops small molecule drugs to treat diseases and disorders of the central nervous system, chronic pain, neuropathic pain, cognitive disorders and alzheimer's disease. It was formerly known as Axonyx, Inc. The company is headquartered in La Jolla, CA. | Health Technology |
| La Jolla Institute for Molecular Medicine | |
UC San Diego Foundation
UC San Diego Foundation Investment Trusts/Mutual FundsMiscellaneous UC San Diego Foundation specializes in obtaining private gifts in support of research, teaching, and public service, as well as engages in management of gift assets. The company is was founded in 1972 and is headquartered in La Jolla, CA. | Miscellaneous |
- Borsa valori
- Insiders
- William T. Comer
